QUADRANT BIOSCIENCES, INC.
SYRACUSE, NY · Founded 2015 · CIK 0001651239 · Medtech · Private
Salivary microRNA biomarker diagnostic assay for mild traumatic brain injury detection in adolescents
- Grants
- $2.9M
- 6 awards
- Sector median: 1
- Raised
- $8.8M
- 6 Form D · Nov 2023
- 35 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152017201920212023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $435,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Validation of a salivary miRNA diagnostic test for autism spectrum disorder | $225,000 | |
| Private capital raised | Form D · SEC | $2,080,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Validation of a salivary miRNA diagnostic test for autism spectrum disorder | $592,573 | |
| Federal grant | Department of Health and Human Services · Phase II · Validation of a salivary miRNA diagnostic test for autism spectrum disorder | $330,000 | |
| Private capital raised | Form D · SEC | $450,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Validation of a salivary miRNA diagnostic test for autism spectrum disorder | $701,023 | |
| Private capital raised | Form D · SEC | $2,300,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Refinement of a rapid saliva miRNA diagnostic test for concussion | $380,848 | |
| Federal grant | Department of Health and Human Services · Phase II · Validation of a salivary miRNA diagnostic test for autism spectrum disorder | $621,969 | |
| Private capital raised | Form D · SEC | $3,500,000 | |
| Private capital raised | Form D · SEC | $25,425,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 741 | Brockman-Hastings LLC | — | — |
| 742 | ASTRADX INC | — | — |
| 743 | OrthoCor Medical, Inc. | — | $16K |
| 744 | QUADRANT BIOSCIENCES, INC. | — | $8.8M |
| 745 | CREATIVE LIBS SOLUTIONS, LLC | — | — |
| 746 | COLLAMEDIX INC. | — | — |
| 747 | Bay Labs, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Erica AshExecutive Officer
- Patrick BaileyExecutive Officer
- Richard BongoDirector · Executive Officer
- Andrew BrindleExecutive Officer
- Randy CarpenterExecutive Officer
- Peter CohenDirector
- James CrokeDirector · Executive Officer
- Ira FedderDirector
- Scott GiambalvoExecutive Officer
- Nicholas GianaddaExecutive Officer
- Bryan GreeneExecutive Officer
- Cindy GreeneDirector
- Chris HoracekExecutive Officer
- David MacLeanDirector · Executive Officer
- Benjamin PerryExecutive Officer
- Alexander RajanExecutive Officer
- Alexander Rajan, PhDExecutive Officer
- Andrew RockDirector
- Mary TyszkoDirector
- Mary Ann TyszkoDirector
- Richard UhligDirector · Executive Officer
- Kayla WagnerExecutive Officer
- Wade WestDirector · Executive Officer
- Gary West, Jr.Director
- Jeremy WilliamsExecutive Officer
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.